Russia's RDIF to invest in coronavirus tests developer Medpromresurs

The Russian Direct Investment Fund (RDIF) said on Thursday it will invest in Medpromresurs, a Russian company that is currently developing coronavirus tests.

RDIF said that its partners in Medpromresurs, established to focus on a new Russian-Japanese diagnostic system for coronavirus, are Japan's К.R. Mirai Genomics and two other Russian firms.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)